Literature DB >> 3056208

Ceftriaxone versus povidone iodine in preventing wound infections following biliary surgery.

R S Kiff1, J Lomax, L Fowler, R D Kingston, E M Hoare, P A Sykes.   

Abstract

The effect of either prophylactic antibiotic or wound antiseptic on bile bacteriology, wound and other postoperative sepsis has been studied in a controlled prospective randomised trial of 243 patients undergoing biliary surgery at a district general hospital. Wound infection rates were significantly less in patients given intravenous ceftriaxone (1%) at induction of anaesthesia when compared to povidone iodine sprayed into the wound at the completion of surgery (9%) (P = 0.02). In all but one patient infected wounds grew organisms identical to those cultured from the bile. There were also fewer chest and urinary infections in the ceftriaxone group but this was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3056208      PMCID: PMC2498829     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  19 in total

1.  Anaerobes in human biliary tracts.

Authors:  D M England; J E Rosenblatt
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

2.  Micro-organisms in the bile. A preventable cause of sepsis after biliary surgery.

Authors:  M R Keighley
Journal:  Ann R Coll Surg Engl       Date:  1977-07       Impact factor: 1.891

3.  Prophylactic use of cephazolin against wound sepsis after cholecystectomy.

Authors:  C J Strachan; J Black; S J Powis; T A Waterworth; R Wise; A R Wilkinson; D W Burdon; M Severn; B Mitra; H Norcott
Journal:  Br Med J       Date:  1977-05-14

4.  The effect of topical povidone iodine on wound infection following abdominal surgery.

Authors:  J G Gray; M J Lee
Journal:  Br J Surg       Date:  1981-05       Impact factor: 6.939

5.  Disinfection of surgical wounds without inhibition of normal wound healing.

Authors:  J Viljanto
Journal:  Arch Surg       Date:  1980-03

6.  Ro 13-9904: A cephalosporin with a high degree of activity and broad antibacterial activity: an invitro comparative study.

Authors:  R Wise; A P Gillett; J M Andrews; K A Bedford
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

7.  Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.

Authors:  M Seddon; R Wise; A P Gillett; R Livingston
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

8.  Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.

Authors:  P Angehrn; P J Probst; R Reiner; R L Then
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

9.  Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

10.  Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.

Authors:  T C Eickhoff; J Ehret
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

View more
  1 in total

1.  A meta-analysis of randomized, controlled trials assessing the prophylactic use of ceftriaxone. A study of wound, chest, and urinary infections.

Authors:  J C Woodfield; N Beshay; A M van Rij
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.